Trending
World Cup 2026ExplainerNoncompete policyCybersecurity lawApp economyWafcon 2026Youth mental healthUfl pipelineAi promptingCosmetics regulationDefense techDownhill skateboardingWtt championsHeritage conservationMetabolic sciencePsychiatric medicineGenerational wealthAntitrust rulingTournament previewData analysisRoster battlesIndustry expansionChampionship raceMedical breakthroughEvidence explainerMyanmar conflictHistoryIndustry shiftPolicy explainerMilestone reportDemographic shift

Health

All HealthNutrition & DietSupplementsMental HealthSleepLongevityMedicineMedications & TreatmentsConditions & DiseasesHormones & EndocrinologySkincareDental HealthFamily HealthChildren's HealthMen's HealthWomen's HealthAging & GeroscienceBiohackingAlternative MedicinePublic HealthMedical ResearchPreventive WellnessHealthy Habits
Sleep Science

Sleep Duration Emerges as Stronger Predictor of Longevity Than Diet or Exercise in Landmark Study

3 sources · 21d ago

Sleep Science

Sleep Duration Emerges as Stronger Predictor of Longevity Than Diet or Exercise in Landmark Study

3 sources · 21d ago

Factlen Research

Landmark Trial Adds Immunotherapy to Chemo, Halving Recurrence Risk in Stage III dMMR Colon Cancer

5 sources · 21d ago

More in Health

Factlen ResearchOncology Breakthrough

Landmark Trial Adds Immunotherapy to Chemo, Halving Recurrence Risk in Stage III dMMR Colon Cancer

Clinical Oncologists 40%Patient Advocacy Groups 30%Regulatory & Industry Analysts 30%

5 sources · 21d ago

Integrative CareExplainer

WHO Adopts Landmark 10-Year Strategy to Integrate Traditional and Complementary Medicine into Global Health Systems

Integrative Health Advocates 40%Scientific Skeptics 30%Global South Policymakers 30%

3 sources · 21d ago

Integrative CareExplainer

WHO Adopts Landmark 10-Year Strategy to Integrate Traditional and Complementary Medicine into Global Health Systems

Integrative Health Advocates 40%Scientific Skeptics 30%Global South Policymakers 30%

3 sources · 21d ago

Thyroid Eye DiseaseExplainer

FDA Approves Lumvoa, First IGF-1R Inhibitor to Treat Thyroid Eye Disease

Clinical Ophthalmologists 35%Patient Advocacy Groups 35%Industry Analysts 30%

5 sources · 21d ago

Thyroid Eye DiseaseExplainer

FDA Approves Lumvoa, First IGF-1R Inhibitor to Treat Thyroid Eye Disease

Clinical Ophthalmologists 35%Patient Advocacy Groups 35%Industry Analysts 30%

5 sources · 21d ago

Factlen ExplainerBrain Stimulation

Landmark Case: Personalized Deep Brain Stimulation Achieves Rapid Symptom Reduction in Severe Treatment-Resistant OCD

Neuromodulation Researchers 40%Clinical Psychiatrists 35%Patient Advocacy Groups 25%

5 sources · 21d ago

Factlen ExplainerPsychedelic Medicine

Single-Dose Psilocybin Therapy Achieves Rapid Reduction in Chronic Suicidal Ideation in Landmark Trial

Psychiatric Researchers 40%Clinical Implementers 30%Patient Advocates 30%

4 sources · 21d ago

Alzheimer's CareExplainer

FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Alzheimer's Dementia

Clinical Neurologists & Geriatricians 40%Patient & Caregiver Advocates 35%Pharmacology & Industry Analysts 25%

6 sources · 21d ago

Alzheimer's CareExplainer

FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Alzheimer's Dementia

Clinical Neurologists & Geriatricians 40%Patient & Caregiver Advocates 35%Pharmacology & Industry Analysts 25%

6 sources · 21d ago

Alzheimer's CareExplainer

FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Alzheimer's Dementia

Clinical Neurologists & Geriatricians 40%Patient & Caregiver Advocates 35%Pharmacology & Industry Analysts 25%

6 sources · 21d ago

Factlen ExplainerIgA Nephropathy

How VOYXACT's APRIL Inhibition is Stabilizing Kidney Function in IgA Nephropathy

Clinical Researchers 40%Regulatory & Medical Consensus 35%Biopharma Developers 25%

3 sources · 21d ago

Factlen ExplainerHER2 Therapies

FDA Approves T-DXd for Early-Stage HER2+ Breast Cancer, Signaling New Standard of Care

Clinical Researchers 47%Regulatory Monitors 35%Industry Analysts 18%

5 sources · 21d ago

Factlen ExplainerParkinson's Disease

The Evidence Pack: How Tavapadon's Phase 3 Data Could Reshape Parkinson's Motor Control

Clinical Researchers 40%Industry & Regulators 30%Patient Advocates 30%

6 sources · 21d ago

Factlen ExplainerDental Tech

Landmark ADA/AAOMR Consensus Recommends Ending Use of Thyroid Shields in Dental X-Rays

Clinical Researchers 40%General Dental Practitioners 35%Patient Safety Advocates 25%

4 sources · 21d ago

CRISPR TherapyExplainer

FDA Expands CRISPR Gene Therapy Approval to Children as Young as Two for Sickle Cell Disease and Beta Thalassemia

Pediatric Hematologists 41%Patient Advocacy Groups 35%Health Economists 24%

3 sources · 22d ago

Factlen ResearchPrecision Immunology

First-in-Class Extracellular Protein Degrader Enters Phase 3 to Target Root Cause of Graves' Disease

Clinical Trial Investigators 41%Targeted Protein Degradation Pioneers 29%Biotech Industry Analysts 29%

6 sources · 22d ago

Factlen Deep DiveCartilage Regeneration

Drug Blocks Aging Protein to Regenerate Lost Cartilage in Mice and Human Samples, Offering Functional Cure for Osteoarthritis

Regenerative Medicine Researchers 40%Orthopedic Specialists 35%Public Health & Patient Advocates 25%

7 sources · 22d ago

Factlen Deep DiveCartilage Regeneration

Drug Blocks Aging Protein to Regenerate Lost Cartilage in Mice and Human Samples, Offering Functional Cure for Osteoarthritis

Regenerative Medicine Researchers 40%Orthopedic Specialists 35%Public Health & Patient Advocates 25%

7 sources · 22d ago

Factlen Deep DiveCartilage Regeneration

Drug Blocks Aging Protein to Regenerate Lost Cartilage in Mice and Human Samples, Offering Functional Cure for Osteoarthritis

Regenerative Medicine Researchers 40%Orthopedic Specialists 35%Public Health & Patient Advocates 25%

7 sources · 22d ago

Factlen ResearchGene Therapy

EC Approves First Gene Replacement Therapy for Adults and Older Children with Spinal Muscular Atrophy

Neuromuscular Specialists 39%Patient Advocacy Groups 33%Regulatory & Industry Bodies 28%

4 sources · 22d ago

Factlen ResearchGene Therapy

EC Approves First Gene Replacement Therapy for Adults and Older Children with Spinal Muscular Atrophy

Neuromuscular Specialists 39%Patient Advocacy Groups 33%Regulatory & Industry Bodies 28%

4 sources · 22d ago

Factlen ExplainerPsychedelic Medicine

The Evidence Pack: How a Single-Dose Lysergide Derivative is Rewriting Depression Treatment

Clinical Researchers 40%Regulatory & Policy Experts 30%Factlen Editorial Synthesis 30%

5 sources · 22d ago

Factlen ExplainerPsychedelic Medicine

The Evidence Pack: How a Single-Dose Lysergide Derivative is Rewriting Depression Treatment

Clinical Researchers 40%Regulatory & Policy Experts 30%Factlen Editorial Synthesis 30%

5 sources · 22d ago

Factlen Deep DiveCellular Reprogramming

First Patient Dosed in Landmark Trial of Systemic Cellular Reprogramming Therapy

Longevity Biotech Industry 45%Cautious Gerontologists 35%Regulatory & Safety Monitors 20%

5 sources · 22d ago

Explore more topics

News & PoliticsWorldBusinessFinanceTechnologyArtificial IntelligenceScienceEnergy